共 303 条
[1]
Goldburg SR(2020)Hidradenitis suppurativa: epidemiology, clinical presentation, and pathogenesis J Am Acad Dermatol 82 1045-1058
[2]
Strober BE(2021)Hidradenitis suppurativa: an update on epidemiology, phenotypes, diagnosis, pathogenesis, comorbidities and quality of life J Eur Acad Dermatol Venereol 35 50-61
[3]
Payette MJ(2019)Substantially reduced life expectancy in patients with hidradenitis suppurativa: a Finnish nationwide registry study Br J Dermatol 180 1543-1544
[4]
Nguyen TV(2022)Comorbidity screening in hidradenitis suppurativa: evidence-based recommendations from the US and Canadian Hidradenitis Suppurativa Foundations J Am Acad Dermatol 86 1092-1101
[5]
Damiani G(2018)T helper 17 cell/regulatory T-cell imbalance in hidradenitis suppurativa/acne inversa: the link to hair follicle dissection, obesity, smoking and autoimmune comorbidities Br J Dermatol 179 260-272
[6]
Orenstein LAV(2021)Hidradenitis suppurativa: pathogenesis, clinical presentation, epidemiology, and comorbid associations Int J Dermatol 60 e449-e458
[7]
Hamzavi I(2020)Hidradenitis suppurativa: current understanding of pathogenic mechanisms and suggestion for treatment algorithm Front Med 7 68-327
[8]
Jemec GB(2021)Hidradenitis suppurativa—the role of interleukin-17, the aryl hydrocarbon receptor and the link to a possible fungal aetiology Med Hypotheses 149 321-891
[9]
Tiri H(2022)Clonally expanded B cells in multiple sclerosis bind EBV EBNA1 and GlialCAM Nature 603 886-e46
[10]
Jokelainen J(2019)Contribution of fibroblasts to tunnel formation and inflammation in hidradenitis suppurativa/ acne inversa Exp Dermatol 28 e36-551